40 related articles for article (PubMed ID: 15749420)
21. miR-124 radiosensitizes human glioma cells by targeting CDK4.
Deng X; Ma L; Wu M; Zhang G; Jin C; Guo Y; Liu R
J Neurooncol; 2013 Sep; 114(3):263-74. PubMed ID: 23761023
[TBL] [Abstract][Full Text] [Related]
22. Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapy.
Nuthalapati S; Zhou Q; Guo P; Lv H; Cosenza S; Reddy MV; Reddy EP; Gallo JM
Pharm Res; 2012 Sep; 29(9):2499-511. PubMed ID: 22678771
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.
Zhang QQ; Xu H; Huang MB; Ma LM; Huang QJ; Yao Q; Zhou H; Qu LH
Neuro Oncol; 2012 Mar; 14(3):278-87. PubMed ID: 22217655
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma.
Ciznadija D; Liu Y; Pyonteck SM; Holland EC; Koff A
Cancer Res; 2011 Oct; 71(19):6174-83. PubMed ID: 21844184
[TBL] [Abstract][Full Text] [Related]
25. Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines.
Wang K; Pan L; Che X; Cui D; Li C
J Neurooncol; 2010 Jul; 98(3):319-27. PubMed ID: 20024601
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors.
Tejada S; Lobo MV; García-Villanueva M; Sacristán S; Pérez-Morgado MI; Salinas M; Martín ME
J Histochem Cytochem; 2009 May; 57(5):503-12. PubMed ID: 19188486
[TBL] [Abstract][Full Text] [Related]
27. Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?
Widera D; Kaus A; Kaltschmidt C; Kaltschmidt B
J Cell Mol Med; 2008 Apr; 12(2):459-70. PubMed ID: 18182066
[TBL] [Abstract][Full Text] [Related]
28. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
30. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
31. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D3 expression in normal, reactive and neoplastic tissues.
Doglioni C; Chiarelli C; Macrí E; Dei Tos AP; Meggiolaro E; Dalla Palma P; Barbareschi M
J Pathol; 1998 Jun; 185(2):159-66. PubMed ID: 9713342
[TBL] [Abstract][Full Text] [Related]
33. The effect of cyclin D expression on cell proliferation in human gliomas.
Zhang X; Zhao M; Huang AY; Fei Z; Zhang W; Wang XL
J Clin Neurosci; 2005 Feb; 12(2):166-8. PubMed ID: 15749420
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
